# A Study of AMDX-2011P in Participants With Alzheimer's Disease

> **NCT06514001** · PHASE2 · RECRUITING · sponsor: **Amydis Inc.** · enrollment: 25 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** AMDX-2011P

## Key facts

- **NCT ID:** NCT06514001
- **Lead sponsor:** Amydis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-07
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06514001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06514001, "A Study of AMDX-2011P in Participants With Alzheimer's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06514001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*